SCHEMBL4501168

SCHEMBL4501168

Cc1cc(C)nc(NC(=O)c2cc(COc3ccc(F)cc3Cl)ccn2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.60
KDM4E B2RXH2 3/20 0.60
KMT2A Q03164 2/20 0.60
MEN1 O00255 1/20 0.60
PKM P14618 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
ALDH1A1 P00352 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.47
POLB P06746 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
GRM5 P41594 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
ADORA1 P30542 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496717 0.92 MAPT (0.60) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4500386 0.89 MAPT (0.74) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4502419 0.86 MAPT (0.59) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4507587 0.84 SMN1; SMN2 (0.59) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4513766 0.83 MAPT (0.48) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4492876 0.78 MAPT (0.52) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4497112 0.78 MRGPRX4 (0.72) KMT2AMEN1SMN1; SMN2MRGPRX4
SCHEMBL4504246 0.77 MRGPRX4 (0.56) MAPTKMT2AMEN1PKMALDH1A1
SCHEMBL4508993 0.76 MRGPRX4 (0.47) MAPTKDM4EKMT2AMEN1PKM
SCHEMBL4509650 0.73 ALDH1A1 (0.53) MAPTKDM4EKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MAPT 4022/4885KDM4E 249/4885KMT2A 1109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.